ProfileGDS5822 / ILMN_2434661
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 28% 43% 4% 40% 49% 2% 24% 6% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.828
GSM1276600PDAC Late Ablation Control 221.443
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 16.64
GSM1276603PDAC Late Ablation 218.540
GSM1276604PDAC Late Ablation 323.649
GSM1303940PDAC Late Ablation_anti-CTLA4 152
GSM1303941PDAC Late Ablation_anti-CTLA4 212.424
GSM1303942PDAC Late Ablation_anti-CTLA4 34.36